Table 3.
Rhythm control strategies | Singh and Vaughan-Williams classification |
Mechanism of action | Reference(s) |
---|---|---|---|
Pharmacological cardioversion | |||
Flecainide | Class Ic | Blocks fast inward sodium channel to reduce rate of rise of AP depolarization and contractility Selectively effects cells with high rates |
(194) |
Propafenone | Class Ic | Blocks fast inward sodium current to reduce rate of rise of AP depolarization and contractility β-adrenergic receptor blocking properties |
(69) |
Ibutilide | Class IIIc | Blocks the delayed rectifier outward potassium current and enhances the slow inward sodium current which both prolong AP duration and conduction |
(128, 260) |
Dofetilide | Class IIIc | Selectively blocks the delayed rectifier outward potassium current to prolong AP |
(202) |
Sotalol | Class IIIc | Blocks the delayed rectifier outward potassium current to prolong AP β-adrenergic receptor blocking properties |
(3) |
Amiodarone | Class IIIc | Multi-channel blocker that effects inward sodium and calcium channels as well as repolarizing outward potassium channels, which ultimately causes prolongation of the repolarization phase of the AP and conduction α- and β-adrenergic receptor and blocking properties |
(124) |
Electrical cardioversion | |||
Direct current (monophasic or biphasic waves) |
Not applicable | Block reentrant electrical circuits by depolarizing atrial tissue using high voltage (monphasic waves) or low-voltage (biphasic) electrical currents to make atria refractory |
(133) |
Ablation therapy | Not applicable | Block reentrant electrical circuits by making lesion/scar lines in and around the pulmonary veins |
(256) |